MRVI · Maravai Lifesciences Holdings, Inc. · Documents
Market Cap
$1.80B
Shares
259.67M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-06-03 | 2026-06-02 | |
| 8-K | 2026-05-29 | 2026-05-26 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-24 | 2026-05-26 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-27 | 2025-10-21 | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | 2025-08-07 | |
| 8-K | 2025-07-18 | 2025-07-16 | |
| 8-K | 2025-06-25 | 2025-06-22 | |
| 8-K | 2025-06-09 | 2025-06-08 | |
| 8-K | 2025-05-28 | 2025-05-22 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-18 | 2025-05-22 | |
| 8-K | 2025-03-20 | — | |
| 8-K | 2025-03-18 | 2025-03-17 | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2025-01-08 | 2025-01-02 | |
| 8-K | 2024-12-18 | — | |
| 8-K | 2024-12-05 | 2024-12-03 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-12 | 2024-09-10 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-07-29 | 2024-07-23 | |
| 8-K | 2024-06-12 | 2024-06-10 | |
| 8-K | 2024-05-28 | 2024-05-23 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-25 | 2024-05-23 | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-02-22 | — | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-08-07 | — | |
| 8-K | 2023-07-27 | — | |
| 8-K | 2023-07-20 | 2023-07-19 | |
| 8-K | 2023-05-22 | 2023-05-18 | |
| 10-Q | 2023-05-09 | 2023-03-31 |
Showing 1–50 of 85 filings
Key facts
CIK
1823239
CUSIP
56600D107
13F (30d)
120 filings
120 filers
Visit website
Investor relations